Pablo Llerena

5PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersCommunication technology and digital media studiesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 19, 2026
Viability of Tumor Cells in Bone Dust: Implications for Oncologic Skull Base Surgery.

|Mar 23, 2026
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy.

Pablo Llerena, Praneet C Kaki, Kathryn Nunes

|Jan 08, 2026
Impact of Multimedia on Patient Comprehension in Thyroid Surgery: A Randomized Trial.

Hani Samarah, Annie E Moroco, Kalena Liu

|Sep 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Pablo Llerena, Hani Samarah, Kathryn Nunes

|Mar 12, 2025
Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer types.

Eric V Mastrolonardo, Pablo Llerena, Emma De Ravin

Pageof 1

Frequent Collaborators

2 joint publications

Kelly Bridgham

2 joint publications

Andrew P South

2 joint publications

Stacey Gargano

1 joint publications

Pablo Llerena